Viscoelastic Hemostatic Assays in Sepsis: From Pathophysiology to Potential Clinical Implications

Abstract

Sepsis is a complex syndrome characterized by physiological, pathological, and biochemical abnormalities induced by infection, with up to 70% of patients experiencing coagulation alterations, ranging from subclinical coagulopathy to disseminated intravascular coagulation (DIC). The multifactorial nature of sepsis-related coagulopathy and the limitations of standard diagnostic parameters, such as platelet count and traditional coagulation tests, complicate its definition and management. Assessing coagulopathy related to sepsis presents significant challenges due to current definitions primarily focusing on diagnosing advanced stages of coagulation dysfunction, thereby overlooking the dynamic and evolving nature of the condition. Viscoelastic hemostatic assays (VHAs) have emerged as valuable tools in this context, offering real-time insights into clot formation, stabilization, and lysis by integrating both plasma and cellular contributions to coagulation. Data from clinical studies suggest that early stages of sepsis coagulopathy are characterized by hypercoagulability, while advanced stages may lead to hypocoagulability and DIC. Moreover, specific point-of-care assays can evaluate platelet performance in the clotting mechanism and potentially help the diagnosis of platelet dysfunction in sepsis. Additionally, the phenomenon of fibrinolysis inhibition contributes to the persistence of fibrin clots, promoting tissue ischemia and multiorgan dysfunction. Modified VHAs appear promising for detecting fibrinolysis impairment, which is associated with poorer outcomes, but the standardization of results is still a work in progress. Incorporating VHAs data into treatment strategies could lead to more targeted therapies, potentially improving outcomes in septic patients by addressing both hypercoagulable and hypocoagulable states, as well as fibrinolysis abnormalities.

Keywords

viscoelastic - thromboelastography - TEG - coagulation - sepsis - septic shock - coagulopathy

^* These authors contributed equally to this article.

Publikationsverlauf

Artikel online veröffentlicht:
24. Mai 2025

• References

• 1 Singer M, Deutschman CS, Seymour CW. et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016; 315 (08) 801-810
• 2 Wheeler AP, Bernard GR. Treating patients with severe sepsis. N Engl J Med 1999; 340 (03) 207-214
• 3 Tsantes AG, Parastatidou S, Tsantes EA. et al. Sepsis-induced coagulopathy: an update on pathophysiology, biomarkers, and current guidelines. Life (Basel) 2023; 13 (02) 350
• 4 Taylor Jr FB, Toh CH, Hoots WK, Wada H, Levi M. Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH). Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 2001; 86 (05) 1327-1330
• 5 Gando S, Iba T, Eguchi Y. et al; Japanese Association for Acute Medicine Disseminated Intravascular Coagulation (JAAM DIC) Study Group. A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: comparing current criteria. Crit Care Med 2006; 34 (03) 625-631
• 6 Iba T, Nisio MD, Levy JH, Kitamura N, Thachil J. New criteria for sepsis-induced coagulopathy (SIC) following the revised sepsis definition: a retrospective analysis of a nationwide survey. BMJ Open 2017; 7 (09) e017046
• 7 Wang B, Zhang B, Shen Y, Li J, Yuan X, Tang N. Validation of two revised, simplified criteria for assessing sepsis-associated disseminated intravascular coagulation in ICU patients with Sepsis-3: a retrospective study. Lab Med 2023; 54 (03) 291-298
• 8 Hartert H. Blutgerinnungsstudien mit der Thrombelastographie; einem neuen Untersuchungsverfahren [Blood clotting studies with Thrombus stressography; a new Investigation procedure] [in German]. Klin Wochenschr 1948; 26 (37-38): 577-583
• 9 Camenzind V, Bombeli T, Seifert B. et al. Citrate storage affects thrombelastograph analysis. Anesthesiology 2000; 92 (05) 1242-1249
• 10 De Falco S, Meli A, Caccioppola A, Grasselli G, Panigada M. Agreement between the thromboelastography reaction time parameter using fresh and citrated whole blood during extracorporeal membrane oxygenation with Teg5000 and Teg6s. Perfusion 2024; 39 (Suppl. 01) 77S-80S
• 11 Faraoni D, DiNardo JA. Viscoelastic hemostatic assays: update on technology and clinical applications. Am J Hematol 2021; 96 (10) 1331-1337
• 12 Brearton C, Rushton A, Parker J, Martin H, Hodgson J. Performance evaluation of a new point of care viscoelastic coagulation monitoring system in major abdominal, orthopaedic and vascular surgery. Platelets 2020; 31 (08) 1052-1059
• 13 Corominas V, Chiniard T, Pasquier P, Foissaud V, de Rudnicki S, Martinaud C. In vitro evaluation of a new viscoelastometry-based point-of-care analyzer. Transfusion 2024; 64 (Suppl. 02) S191-S200
• 14 Panigada M, Meli A, Forastieri Molinari A. et al. Agreement between viscoelastic coagulation monitor (VCM), TEG 5000, and coagulation tests in critically ill patients: a multicenter study. ASAIO J 2023; 69 (06) e230-e239
• 15 Davies GR, Lawrence M, Pillai S. et al. The effect of sepsis and septic shock on the viscoelastic properties of clot quality and mass using rotational thromboelastometry: a prospective observational study. J Crit Care 2018; 44: 7-11
• 16 Massion PB, Peters P, Ledoux D. et al. Persistent hypocoagulability in patients with septic shock predicts greater hospital mortality: impact of impaired thrombin generation. Intensive Care Med 2012; 38 (08) 1326-1335
• 17 Kim SM, Kim SI, Yu G. et al. Role of thromboelastography in the evaluation of septic shock patients with normal prothrombin time and activated partial thromboplastin time. Sci Rep 2021; 11 (01) 11833
• 18 Boscolo A, Spiezia L, Campello E. et al. Whole-blood hypocoagulable profile correlates with a greater risk of death within 28 days in patients with severe sepsis. Korean J Anesthesiol 2020; 73 (03) 224-231
• 19 Adamzik M, Görlinger K, Peters J, Hartmann M. Whole blood impedance aggregometry as a biomarker for the diagnosis and prognosis of severe sepsis. Crit Care 2012; 16 (05) R204
• 20 Davies GR, Mills GM, Lawrence M. et al. The role of whole blood impedance aggregometry and its utilisation in the diagnosis and prognosis of patients with systemic inflammatory response syndrome and sepsis in acute critical illness. PLoS One 2014; 9 (09) e108589
• 21 Kim SM, Kim SI, Yu G. et al. Role of thromboelastography as an early predictor of disseminated intravascular coagulation in patients with septic shock. J Clin Med 2020; 9 (12) 1-11
• 22 Saraiva IEB, Miranda PK, Freitas JN. et al. Thromboelastometric evaluation of sepsis associated coagulopathy: a cohort study. Thromb Res 2016; 147: 124-125
• 23 Hu YL, McRae HL, Refaai MA. Efficacy of viscoelastic hemostatic assay testing in patients with sepsis-induced disseminated intravascular coagulation. Eur J Haematol 2021; 106 (06) 873-875
• 24 Adamzik M, Langemeier T, Frey UH. et al. Comparison of thrombelastometry with simplified acute physiology score II and sequential organ failure assessment scores for the prediction of 30-day survival: a cohort study. Shock 2011; 35 (04) 339-342
• 25 Luo C, Hu H, Gong J, Zhou Y, Chen Z, Cai S. The value of thromboelastography in the diagnosis of sepsis-induced coagulopathy. Clin Appl Thromb Hemost 2020; 26 (1023) 1076029620951847
• 26 Müller MC, Meijers JC, Vroom MB, Juffermans NP. Utility of thromboelastography and/or thromboelastometry in adults with sepsis: a systematic review. Crit Care 2014; 18 (01) R30
• 27 Gall LS, Brohi K, Davenport RA. Diagnosis and treatment of hyperfibrinolysis in trauma (a European perspective). Semin Thromb Hemost 2017; 43 (02) 224-234
• 28 Lorente JA, García-Frade LJ, Landín L. et al. Time course of hemostatic abnormalities in sepsis and its relation to outcome. Chest 1993; 103 (05) 1536-1542
• 29 Iba T, Umemura Y, Wada H, Levy JH. Roles of coagulation abnormalities and microthrombosis in sepsis: pathophysiology, diagnosis, and treatment. Arch Med Res 2021; 52 (08) 788-797
• 30 Kiliç Y, Topçu İ, Bambal H, Çivi M. Thromboelastography in the evaluation of coagulation disorders in patients with sepsis. Turk J Med Sci 2014; 44 (02) 267-272
• 31 Muzaffar SN, Baronia AK, Azim A. et al. Thromboelastography for evaluation of coagulopathy in nonbleeding patients with sepsis at intensive care unit admission. Indian J Crit Care Med 2017; 21 (05) 268-273
• 32 Panigada M, Bottino N, Tagliabue P. et al. Hypercoagulability of COVID-19 patients in intensive care unit: a report of thromboelastography findings and other parameters of hemostasis. J Thromb Haemost 2020; 18 (07) 1738-1742
• 33 Boss K, Kribben A, Tyczynski B. Pathological findings in rotation thromboelastometry associated with thromboembolic events in COVID-19 patients. Thromb J 2021; 19 (01) 10
• 34 Ostrowski SR, Windeløv NA, Ibsen M, Haase N, Perner A, Johansson PI. Consecutive thrombelastography clot strength profiles in patients with severe sepsis and their association with 28-day mortality: a prospective study. J Crit Care 2013; 28 (03) 317.e1-317.e11
• 35 Haase N, Ostrowski SR, Wetterslev J. et al. Thromboelastography in patients with severe sepsis: a prospective cohort study. Intensive Care Med 2015; 41 (01) 77-85
• 36 Ninan K F, Iyadurai R, Varghese JK. et al. Thromboelastograph: a prognostic marker in sepsis with organ dysfunction without overt bleeding. J Crit Care 2021; 65: 177-183
• 37 Boscolo A, Spiezia L, De Cassai A. et al. Are thromboelastometric and thromboelastographic parameters associated with mortality in septic patients? A systematic review and meta-analysis. J Crit Care 2021; 61: 5-13
• 38 Kim SM, Kim SI, Yu G, Kim JS, Hong SI, Kim WY. Hypercoagulability in septic shock patients with thrombocytopenia. J Intensive Care Med 2022; 37 (06) 721-727
• 39 Cattano D, Altamirano AV, Kaynak HE. et al. Perioperative assessment of platelet function by thromboelastograph platelet mapping in cardiovascular patients undergoing non-cardiac surgery. J Thromb Thrombolysis 2013; 35 (01) 23-30
• 40 Collyer TC, Gray DJ, Sandhu R, Berridge J, Lyons G. Assessment of platelet inhibition secondary to clopidogrel and aspirin therapy in preoperative acute surgical patients measured by thrombelastography platelet mapping. Br J Anaesth 2009; 102 (04) 492-498
• 41 Moore HB, Moore EE, Neal MD. et al. Fibrinolysis shutdown in trauma: historical review and clinical implications. Anesth Analg 2019; 129 (03) 762-773
• 42 Mavrommatis AC, Theodoridis T, Economou M. et al. Activation of the fibrinolytic system and utilization of the coagulation inhibitors in sepsis: comparison with severe sepsis and septic shock. Intensive Care Med 2001; 27 (12) 1853-1859
• 43 Schmitt FCF, Manolov V, Morgenstern J. et al. Acute fibrinolysis shutdown occurs early in septic shock and is associated with increased morbidity and mortality: results of an observational pilot study. Ann Intensive Care 2019; 9 (01) 19
• 44 Semeraro F, Colucci M, Caironi P. et al. Platelet drop and fibrinolytic shutdown in patients with sepsis. Crit Care Med 2018; 46 (03) e221-e228
• 45 Savioli M, Cugno M, Polli F. et al. Tight glycemic control may favor fibrinolysis in patients with sepsis. Crit Care Med 2009; 37 (02) 424-431
• 46 Panigada M, Zacchetti L, L'Acqua C. et al. Assessment of fibrinolysis in sepsis patients with urokinase modified thromboelastography. PLoS One 2015; 10 (08) e0136463
• 47 Coupland LA, Rabbolini DJ, Schoenecker JG. et al. Point-of-care diagnosis and monitoring of fibrinolysis resistance in the critically ill: results from a feasibility study. Crit Care 2023; 27 (01) 55
• 48 Hammer S, Häberle H, Schlensak C. et al. Severe SARS-CoV-2 infection inhibits fibrinolysis leading to changes in viscoelastic properties of blood clot: a descriptive study of fibrinolysis in COVID-19. Thromb Haemost 2021; 121 (11) 1417-1426
• 49 Brewer JS, Hvas CL, Hvas AM, Larsen JB. Impaired whole-blood fibrinolysis is a predictor of mortality in intensive care patients. TH Open 2024; 8 (01) e164-e174
• 50 Wang C, Chi C, Guo L. et al. Heparin therapy reduces 28-day mortality in adult severe sepsis patients: a systematic review and meta-analysis. Crit Care 2014; 18 (05) 563
• 51 Zarychanski R, Abou-Setta AM, Kanji S. et al; Canadian Critical Care Trials Group. The efficacy and safety of heparin in patients with sepsis: a systematic review and metaanalysis. Crit Care Med 2015; 43 (03) 511-518
• 52 Fan Y, Jiang M, Gong D, Zou C. Efficacy and safety of low-molecular-weight heparin in patients with sepsis: a meta-analysis of randomized controlled trials. Sci Rep 2016; 6 (May): 25984
• 53 Fu S, Yu S, Wang L, Ma X, Li X. Unfractionated heparin improves the clinical efficacy in adult sepsis patients: a systematic review and meta-analysis. BMC Anesthesiol 2022; 22 (01) 28
• 54 Vincent JL, Francois B, Zabolotskikh I. et al; SCARLET Trial Group. Effect of a recombinant human soluble thrombomodulin on mortality in patients with sepsis-associated coagulopathy: the SCARLET randomized clinical trial. JAMA 2019; 321 (20) 1993-2002
• 55 Gando S, Saitoh D, Ishikura H. et al; Japanese Association for Acute Medicine Disseminated Intravascular Coagulation (JAAM DIC) Study Group for the JAAM DIC Antithrombin Trial (JAAMDICAT). A randomized, controlled, multicenter trial of the effects of antithrombin on disseminated intravascular coagulation in patients with sepsis. Crit Care 2013; 17 (06) R297
• 56 Egi M, Ogura H, Yatabe T. et al. The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2020 (J-SSCG 2020). Acute Med Surg 2021; 8 (01) e659
• 57 Allingstrup M, Wetterslev J, Ravn FB, Møller AM, Afshari A. Antithrombin III for critically ill patients: a systematic review with meta-analysis and trial sequential analysis. Intensive Care Med 2016; 42 (04) 505-520
• 58 Hagiwara A, Tanaka N, Uemura T, Matsuda W, Kimura A. Can recombinant human thrombomodulin increase survival among patients with severe septic-induced disseminated intravascular coagulation: a single-centre, open-label, randomised controlled trial. BMJ Open 2016; 6 (12) e012850
• 59 Iba T, Helms J, Levy JH. The role of viscoelastic tests in the diagnosis of sepsis-induced coagulopathy (SIC). Ann Intensive Care 2025; 15 (01) 19